We accordingly observed a significant reduction in the expression of a large set of IFN-induced genes such as IRF7 or ISG15 that, prior to CD19 CAR T cell therapy, were primarily expressed within monocyte and T cell subsets of this cohort of patients with SLE (Figure 1, F and G). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.